Celularity Inc.
CELU$39M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaFLORHAM PARK
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
CELU News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
PDA-002
Diabetic Nephropathies
Human Placenta-Derived Cells PDA001 Intravenous Infusion
Crohn's Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
PDA-002 | Phase 2 | Diabetic Nephropathies | - | - |
Human Placenta-Derived Cells PDA001 Intravenous Infusion | Phase 2 | Crohn's Disease | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply